The diagnostic and prognostic value of tau‐PET in amnestic MCI with different FDG‐PET subtypes
Abstract Objectives Mild cognitive impairment presenting with an amnestic syndrome (aMCI) and amyloid positivity is considered due to AD. Many subjects, however, can show an overall very slow progression relevant for differential diagnosis, prognosis, and treatment. This study assessed PET biomarker...
Enregistré dans:
| Auteurs principaux: | , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Wiley
2024-05-01
|
| Collection: | Annals of Clinical and Translational Neurology |
| Accès en ligne: | https://doi.org/10.1002/acn3.52039 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|